In vitro Antitumor Activity, Intracellular Accumulation, and DNA Adduct Formation of cis-[((1R,2R)-1,2-Cyclohexanediamine-N,N')bis(myristato)] Platinum (II) Suspended in Lipiodol

スポンサーリンク

概要

• 論文の詳細を見る
• 2000-01-31

著者

• 竹内 洋文

  50周年誌編集小委員会

• Fukushima S

  Lab. Of Clinical Pharmaceutics Fac. Of Pharmaceutical Sciences Kobe Gakuin Univ.

• Takeuchi Yoshikazu

  Lab. Of Clinical Pharmaceutics Fac. Of Pharmaceutical Sciences Kobe Gakuin Univ.

• KISHIMOTO Shuichi

  Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University

• TAKEUCHI Yoshikazu

  Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University

• MIYAZAWA Kenji

  Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University

• 竹内 豊

  Research Center Sumitomo Pharmaceuticals Co. Ltd.

• Takeuchi Yoshikazu

  Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Kobe Gakuin University

• Kishimoto Shuichi

  Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Kobegakuin University

• Kishimoto Shuichi

  Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Kobe Gakuin University

• FUKUSHIMA Syoji

  Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University

• Takeuchi Y

  Faculty Of Pharmaceutical Sciences Okayama University

• Miyawaki Kohji

  Department Of Pharmaceutics Faculty Of Pharmaceutical Science Kobe Gakuin University

• Yamaoka Takashi

  Pharmacology Research Laboratories Dainippon Sumitomo Pharma Co. Ltd

• Takeuchi Y

  Research Center Sumitomo Pharmaceuticals Co. Ltd.

• Fukushima S

  Department Of Pathology Osaka City University Medical School

• Fukushima S

  Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Kobe Gakuin University

• Miyazawa Kenji

  Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Kobe Gakuin University

関連論文

• Stability of a 1β-Methylcarbapenem Antibiotic, Meropenem (SM-7338) in Aqueous Solution
• The Stability of a Novel Carbapenem Antibiotic, Meropenem (SM-7338), in a Solid State Formulation for Injection
• Quantitative Determination of Ergothioneine in Plasma and Tissues by TLC-Densitometry
• 01P2-143 血中エフェドリン濃度を指標とした葛根湯エキス製剤投与スケジュールの改善
• Continuous Exposure to Low-Dose Cisplatin and Apoptosis(Miscellaneous)
• Relation between Intracellular Accumulation and Cytotoxic Activity of cis-[((1Rl,2R)-l,2-Cyclohexanediamine-N,N')bis(myristato)]platinuni(II) Suspended in Lipiodol
• Transdermal Drug Delivery by Electroporation Applied on the Stratum Corneum of Rat Using Stamp-Type Electrode and Frog-Type Electrode in Vitro
• Cytotoxicity of cis-[((1R,2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]-platinum (II) Suspended in Lipiodol in a Newly Established Cisplatin-resistant Rat Hepatoma Cell Line
• Use of Electroporation to Accelerate the Skin Permeability Enhancing Action of Oleic Acid
• In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
• In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
• Petroselinic Acid and Oleic Acid : Comparison of Enhanced Skin Permeability Relative to Affinity for Saturated Fatty Acids of Stratum Corneum
• Antitumor Effects of a Novel Lipophilic Platinum Complex (SM-11355) against a Slowly-Groing Rat Hepatic Tumor after Intra-Hepatic Arterial Administration
• Asclepic Acid(cis-ω7-Octadecenoic Acid) as a Skin Penetration Enhancer : Its Behavior and Effects on Rat Stratum Corneum and Dermis
• Enhancement of Propylene Glycol Distribution in the Skin by High Purity cis-Unsaturated Fatty Acids with Different Alkyl Chain Lengths Haiving Different Double Bond Position
• Skin Penetration Enhancing Action of cis-Unsaturated Fatty Acids with ω-9,and ω-12-Chain Lengths
• Enhancement of Propylene Glycol Permeation into Rat Dermis Using High-purity Oleic Acid and Subsequent Alteration of the Dermal Protein Structures
• Relation between Intracellular Accumulation and Cytotoxic Activity of cis-[((1Rl,2R)-l,2-Cyclohexanediamine-N,N')bis(myristato)]platinuni(II) Suspended in Lipiodol
• Cytotoxicity of cis-[((1R,2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]-platinum (II) Suspended in Lipiodol in a Newly Established Cisplatin-resistant Rat Hepatoma Cell Line
• In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
• In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
• Relation between Intracellular Accumulation and Cytotoxic Activity of cis-[((1Rl,2R)-l,2-Cyclohexanediamine-N,N')bis(myristato)]platinuni(II) Suspended in Lipiodol
• Cytotoxicity of cis-[((1R,2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]-platinum (II) Suspended in Lipiodol in a Newly Established Cisplatin-resistant Rat Hepatoma Cell Line
• In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
• In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
• Relation between Intracellular Accumulation and Cytotoxic Activity of cis-[((1Rl,2R)-l,2-Cyclohexanediamine-N,N')bis(myristato)]platinuni(II) Suspended in Lipiodol
• Cytotoxicity of cis-[((1R,2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]-platinum (II) Suspended in Lipiodol in a Newly Established Cisplatin-resistant Rat Hepatoma Cell Line
• In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
• In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
• Relation between Intracellular Accumulation and Cytotoxic Activity of cis-[((1Rl,2R)-l,2-Cyclohexanediamine-N,N')bis(myristato)]platinuni(II) Suspended in Lipiodol
• Cytotoxicity of cis-[((1R,2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]-platinum (II) Suspended in Lipiodol in a Newly Established Cisplatin-resistant Rat Hepatoma Cell Line
• In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
• In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
• Effects of Fatty Acids, Fatty Amines and Propylene Glycol on Rat Stratum Corneum Lipids and Proteins in Vitro Measured by Fourier Transform Infrared/Attenuated Total Reflection (FT-IR/ATR) Spectroscopy
• Destabilization of Whole Skin Lipid Bio-liposomes Induced by Skin Penetration Enhancers and FT-IR/ATR (Fourier Transform Infrared/Attenuated Total Reflection) Analysis of Stratum Corneum Lipids
• Microgranulation and Encapsulation of Pulverized Pharmaceutical Powders with Ethyl Cellulose by the Wurster Process
• Effect of Additives on Physical Properties of Fine Ethyl Cellulose Microcapsules Prepared by the Wurster Process
• Coating of Pharmaceutical Powders by Fluidized Bed Process. IV. : Softening Temperature of Acrylic Copolymers and Its Relation to Film-Formation in Aqueous Coating
• Coating of Pharmaceutical Powders by Fluidized Bed Process. III. : Aqueous Coating with Ethyl Acrylate-Methyl Methacrylate-2-Hydroxyethyl Methacrylate Copolymer and the Dissolution Properties of the Products
• Coating of Pharmaceutical Powders by Fluidized Bed Process. II. : Microcapsules Produced by Layering of Fine Powder on Coarse Particles and Subsequent Aqueous Enteric Coating
• 緑茶アミノ酸テアニンの組織分布とGlutamate Transporter介在性制癌剤効果増強
• Behavior of Propylene Glycol (PG) in Dermis after Treatment of Rat Intact Skin Surface with Fatty Acids, Fatty Amines or Azone Dissolved in PG
• Effects of Oleic Acid/Propylene Glycol on Rat Abdominal Stratum Corneum : Lipid Extraction and Appearance of Propylene Glycol in the Dermis Measured by Fourier Transform Infrared/Attenuated Total Reflectance (FT-IR/ATR) Spectroscopy
• Cancer Electrochemotherapy(癌電気化学療法)に関する研究(その13)低電圧電気パルスを併用した場合の抗腫瘍効果の検討
• Electroporation法とIontophoresisの併用によるインスリンの皮膚透過促進効果
• Diltiazem とAprindine の薬物相互作用(第2報) : ヒト肝ミクロゾームによる検討
• 粉体工学会の未来を考える
• 創立から25周年までの歩み
• CDDP耐性肝癌株(H4-II-E/CDDP)におけるCDDPの細胞内取り込みの変化
• SM-11355/リピオドール懸濁液の作用機序 - 投与剤形における in vitro 細胞増殖制御効果と細胞内取りこみ挙動の評価 -
• 13P-7-39 C 型慢肝炎患者における血漿中グルタチオン濃度とインターフェロン治療効果との関連
• Cancer Electrochemotherapy (癌電気化学療法)に関する研究(その7) : ブレオマイシン投与を電気パルス負荷前あるいは負荷後に行った場合の増殖抑制効果の比較
• リポソーム中の脂質の過酸化に対するタウリンの抑制作用
• Protective Effects of Some Neutral Amino Acids against Hypotonic Hemolysis
• Altered Expression of Nuclear Receptors Affects the Expression of Metabolic Enzymes and Transporters in a Rat Model of Cholestasis
• A New Antitumor Agent Amrubicin Induces Cell Growth Inhibition by Stabilizing Topoisomerase II-DNA Complex
• Effect of +36T > C in intron 1 on the glutamine : fructose-6-phosphate amidotransferase 1 gene and its contribution to type 2 diabetes in different populations
• Pharmacokinetics of Ephedrine and Pseudoephedrine after Oral Administration of Kakkonto to Healthy Male Volunteers
• In vitro Antitumor Activity, Intracellular Accumulation, and DNA Adduct Formation of cis-[((1R,2R)-1,2-Cyclohexanediamine-N,N')bis(myristato)] Platinum (II) Suspended in Lipiodol
• Computer Simulation of Agglomeration in the Wurster Process
• Coating of Pharmaceutical Powders by Fhiidized Bed Process. I. Aqueous Enteric Coating with Methacrylic Acid-Ethylacrylate Copolymer and the Dissolution Behavior of Products(Pharmaceutical)
• Physical Characterization of Erythromycin Dihydrate, Anhydrate and Amorphous Solid and Their Dissolution Properties
• 細粒と粉末の混合に関する研究(第2報)細粒と微粉砕粉末の混合状態
• 細粒と粉末の混合--混合性におよぼす粉末粒子径と付着力の効果 (〔粉体工学会〕夏期シンポジウム特集)
• SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population
• No evidence for association of the ENPP1 (PC-1) K121Q variant with risk of type 2 diabetes in a Japanese population
• Anticancer Activity of Free γ-Linolenic Acid on AH-109A Rat Hepatoma Cells and the Effect of Serum Albumin on Anticancer Activity of γ-Linolenic Acid in Vitro
• Isolation of Differentiated Squamous and Undifferentiated Spindle Carcinoma Cell Lines with Differing Metastatic Potential from a 4-Nitroquinoline N-Oxide-induced Tongue Carcinoma in a F344 Rat
• Infrequent Detectable Somatic Mutations of the RET and Glial Cell Line-derived Neurotrophic Factor (GDNF) Genes in Human Pituitary Adenomas
• Synthesis and Antitumor Activity of Fused Quinoline Derivatives. V. Methylindolo[3,2-b]quinolines
• Synthese and Antifungal Activity of dl-Griseofulvin and Its Congeners. III
• Synthesis and Antitumor Activity of Fused Quinoline Derivatives. IV. Novel 11-Aminoindolo[3,2-b]quinolines
• Syntheses and Antifungal Activity of dl-Griseofulvin and Its Congeners. II
• MOLECULAR MODIFICATION AND STRUCTURE-ACTIVITY RELATIONSHIP OF ANTITUMOR ACTIVE INDOLOQUINOLINE DERIVATIVES
• Intramolecular Michael Reaction in Diastereoselective Synthesis of dl-Griseofulvin
• STUDY ON STRUCTURE-ACTIVITY RELATIONSHIP USING MOLECULAR ORBITAL METHOD (PM3)
• SYNTHESIS AND ANTITUMOR ACTIVITY OF FUSED TETRACYCLIC QUINOLINE DERIVATIVES
• The Rate of Cell Growth Is Regulated by Purine Biosynthesis via ATP Production and G1 to S Phase Transition
• Total Synthesis of the Siderophore Vibrioferrin
• Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats
• Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo
• Amrubicin induces apoptosis in human tumor cells mediated by the activation of caspase-3/7 preceding a loss of mitochondrial membrane potential
• Uptake and Intracellular Distribution of Amrubicin, a Novel 9-Amino-anthracycline, and Its Active Metabolite Amrubicinol in P388 Murine Leukemia Cells
• Cytotoxicity of Amrubicin, a Novel 9-Aminoanthracycline, and Its Active Metabolite Amrubicinol on Human Tumor Cells
• Tumor-selective Distribution of an Active Metabolite of the 9-Aminoanthracycline Amrubicin
• In vivo Efficacy and Tumor-selective Metabolism of Amrubicin to Its Active Metabolite
• Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers

もっと見る 閉じる

スポンサーリンク